Immutep (IMMP) Prepaid Assets (2011 - 2025)
Immutep's (IMMP) quarterly Prepaid Assets came in at $2.6 million in Q4 2025, down 48.55% YoY from $5.0 million in Q4 2024, and down 57.7% on a QoQ basis from $6.1 million in Q2 2025.
Immutep (IMMP) Prepaid Assets (2011 - 2025) Analysis & Trends
Immutep (IMMP) has 15 years of Prepaid Assets data on file, last reported at $2.6 million in Q4 2025.
- Quarterly Prepaid Assets fell 48.55% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (down 48.55% YoY) and the FY2025 annual result came in at $6.1 million, up 335.92% from the prior year.
- Prepaid Assets fell to $2.6 million in Q4 2025, from $6.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $6.1 million in Q2 2025 to a low of $1.2 million in Q4 2022.
- A 5-year average of $2.6 million and a median of $2.1 million in 2021 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 335.92% in 2025, down 48.55% in 2025.
- Tracing IMMP's Prepaid Assets over 5 years: stood at $2.1 million in 2021, then plunged by 42.51% to $1.2 million in 2022, then soared by 71.65% to $2.1 million in 2023, then jumped by 140.77% to $5.0 million in 2024, then sank by 48.55% to $2.6 million in 2025.
- The last three Prepaid Assets figures came in at $2.6 million (Q4 2025), $6.1 million (Q2 2025), and $5.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.58 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Dec 31, 2021 | 2.11 Mn |
| Jun 30, 2021 | 1.31 Mn |
| Dec 31, 2020 | 1.52 Mn |
| Jun 30, 2020 | 1.01 Mn |
| Dec 31, 2019 | 1.09 Mn |
| Jun 30, 2019 | 1.25 Mn |
| Dec 31, 2018 | 479,948.32 |
| Jun 30, 2018 | 1.31 Mn |
| Jun 30, 2017 | 635,659.16 |
| Mar 31, 2017 | 625,618.67 |
| Jun 30, 2016 | 465,210.54 |
| Jun 30, 2015 | 736,999.13 |